Innere Medizin (Heidelberg, Germany)HumansAntitubercular AgentsImmunocompromised HostImmunosuppression TherapyImmunosuppressive Agents
[Positive interferon-gamma release assay and immunosuppression: guideline-based diagnosis and treatment of tuberculosis infection].
Carola Horn-Magar, Jonathan Steinke, Philipp Köhler, Jan Rybniker, Isabelle Suárez
Published: 202610.1007/s00108-025-02039-4
Abstract
With the growing use of immunosuppressive therapies, clinicians are increasingly faced with the question of how to manage positive interferon-gamma release assays (IGRA). A tuberculosis infection (TBI, formerly referred to as "latent tuberculosis") i…
Preview only. Read the full abstract at the source